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Abstract 
Background:  Low back pain (LBP) is one of the most common and costly chronic diseases in the world 
today. The use of herbal medicines based on Colchicum autumnal is one of the solutions recommended by Persian 
medicine for treatment of LBP. One of these products is Rhazes tablet. This study aimed to determine effect of the 
Rhazes tablet on LBP pain relief and symptoms. Methods: Fifty patients with chronic LBP, aged 19-59 years old, 
who had LBP for more than 12 weeks, were enrolled in the study. Patients were randomly divided in to 
intervention group (n=26) and control group (n=24). The patients in the intervention and control groups were 
treated with Rhazes tablet + Ibuprofen pearl (400mg) PRN and placebo tablet + Ibuprofen pearl (400mg) PRN, 
respectively. All patients received one tablet in the first week, 2 tablets in week 2-4 and 3 tablets in week 5-8. Pain 
severity was measured and recorded using VAS and Roland-Morris Disability Questionnaire for all patients at 
weeks 0, 4 and 8. Results: The results indicated that Rhazes tablet as a traditional Persian medicine caused a 
significant reduction in LBP in the intervention group compared to control group (P<0.039). Using the Rhazes 
tablet for 8 weeks reduced pain severity in the group suffering from severe pain from 50% in the first visit to 15.4% 
in the third visit; while the pain severity was increased from 20% to 25% in the control group.  In the intervention 
group, a woman in the fifth week of study got severe diarrhea, and the severity was decreased by reducing the 
number of Rhazes tablet. In the intervention group, a man experienced increased libido in the fourth week of study. 
Conclusion: Rhazes tablet can be used as a pharmacological intervention to reduce pain in patients with LBP. 
Results showed promising effects of Rhazes tablet on pain relief and LBP symptoms.  
Keywords: Low back pain, traditional Iranian medicine, Rhazes tablet, Colchicum autumnal, disability, medicinal 
plant. 
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Introduction 
Low back pain (LBP) is one of the most common 
social and economic problems in today's world. It is 
also the second most common reason for referral to 
doctors and the absenteeism from work after common 
cold and the fifth common cause of hospitalization and 
the third most common cause of surgery (1, 2). The 
annual rate of LBP is 30-40%, and 75-85% of people 
experience LBP in their lifetime in some ways. The 
prevalence of LBP in the United States is between 15% 
and 20%, 25 to 45% in Europe, 28.5% in Canada and in 
Iran (3, 4). There are various methods to reduce the LBP 
complications, such as early startup, restoration of 
natural physical activity (without heavy work), 
pharmacological interventions including non-steroidal 
anti-inflammatory drugs (NSAID), physiotherapy, 
medical belts and surgery that induce temporary relief in 
many cases (5). Considering the high prevalence of LBP 
and its complications, finding new treatment strategies 
in this field is valuable in order to achieve low cost and 
effective treatment with the least adverse effects. 
Traditional medicines are sources of thousand years’ 
human medical experiences and a good resources of 
medical hypothesis for clinical trials (6, 7). Rhazes (Al-
Razi or Rasis) (854–925 AC), was a Persian polymath, 
physician, alchemist, philosopher, and important figure 
in the history of medicine, invented a tablet (an herbal 
product based on Colchicum autumnal for treatment of 
LBP. This herbal Formula has been introduced in 
Persian medicine literatures as a affective treatment for 
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LBP. The aim of this study is to determine the effect of 
Rhazes tablet on patients with chronic LBP in a 
randomized double-blinded controlled trial. 
 
Materials and methods 
Study setting and sample recruitment 
After receiving approval from the ethics 
committee of Tehran University of Medical Sciences 
(No. 1395.462) and registration in the Iranian registry of 
clinical trials (IRCT20180227038884N1), this 
randomized controlled trial was conducted on 50 
patients with chronic LBP. The patients were visited by 
the same physician at days 0, 28, 56 from the beginning 
of the intervention. All patients had been filled Informed 
consent form after explaining the aims, advantages and 
disadvantages of the study. 
 
Preparation of the drug and placebo 
Rhazes tablets 
The product is composed of powder of 
Colchicum autumnale (Root), Terminalia Chebula 
(Fruit), Aloe vera (Powder of dried latex of leaves), 
Astragalus gossypinus (Gum), Cuminum cyminum 
(Fruit), Zingiber officinale (Rhizome), Piper nigrum 
(Fruit), Commiphora wightii (Gum), and Pistacia 
lentiscus (Gum) in the same weight.  
Dried samples of above herbs were purchased 
from the traditional herbal market, Tehran, Iran. 
Authentication and deposition of the herbs and 
preparation of the Rhazes tablets were conducted at Niak 
lab.  
 
Determination of total phenolic content 
Total phenolic content of each tablet was 
determined using folin-ciocalteu reagent (8) . For this 
purpose, tablet was powdered. Distilled water was added 
to powdered tablet (150 mg) up to 10 mL. The mixture 
was sonicated for 5 min and then filtered. Filtrate (1 mL) 
was mixed with folin-ciocalteu reagent (1.5 mL) which 
previously diluted 10-fold with distilled water, and 
allowed to stand at room temperature for 5 min. 1.5 mL 
of bicarbonate solution (60 g/L) was added to the 
mixture. After incubation for 90 min at room 
temperature, the absorbance was measured at 725 nm 
using a UV-visible spectrophotometer (GBC, Cintra 40). 
Total phenolics were quantified by calibration curve 
obtained from measuring the absorbance of the known 
concentrations of gallic acid standard solutions. All tests 
were carried out in triplicate and the results were 
expressed as gallic acid equivalents (mg GAE/g dry 
weight). 
 
Determination of total flavonoid content  
Total flavonoid content of each tablet was 
determined by the aluminum chloride colorimetric 
method(8) . For this purpose, tablet was powdered. 
Distilled water was added to powdered tablet (400 mg) 
up to 10 mL. The mixture was sonicated for 5 min and 
then filtered. Concisely, 1 mL of filtrate was added to 
10 mL volumetric flask containing 4 mL of double 
distilled water. 0.3 mL NaNO2 (5%) was added to the 
flask and 5 min later 0.3 mL AlCl3 (10%) was added. 
After 6 min, 2 mL NaOH (1 M) was added and the total 
volume was made up to 10 mL and the flask contents 
were thoroughly mixed. The absorbance level was 
measured versus blank at 510 nm (GBC, Cintra 40). 
Total flavonoid contents were represented as mg 
catechin equivalents (CE) per one gram dry extract 
according to the catechin standard solutions.  
 
Placebo tablets 
The placebo was made from starch, which 
looked exactly like a drug in terms of color, appearance, 
weight, and size.  
 
Patient selection 
This double-blind, randomized clinical trial was 
conducted in School of Persian medicine, Tehran 
University of Medical Sciences in Tehran. Fifty patients 
with chronic LBP, aged 19-59 years old, who had LBP 
for more than 12 weeks, were enrolled in the study. 
Patients were randomly divided in the intervention 
group (n=26) and control group (n=24). The study was 
designed double blind for the physician and the patients 
and simple method was used for randomization. 
The inclusion criteria included patients aged 19 
to 59 years with chronic LBP complaints, no surgical 
indication and no history of trauma, suspected 
malignancy and steroid use, and chronic infection, non-
pregnant and non-lactating women. The subjects were 
divided into two groups. The intervention group were 
treated with Rhazes tablet + Ibuprofen pearl (400mg) 
PRN and placebo group which were treated with 
placebo tablet + Ibuprofen pearl (400mg). All patients 
received one tablet in the first week, 2 tablets in 2-4 
weeks and 3 tablets in 5-8 weeks 1 hour after each meal 
(breakfast, lunch, and dinner). In all samples, the VAS 
and Roland-Morris Disability Questionnaire (RMDQ) at 
weeks 0,4, and 8 was completed and recorded in the 
patients' profile along with Ibuprofen registration sheet 
and drug complications report paper at the beginning of 
the treatment (week zero) and the end of weeks 4 and 8. 
While extracting the results, only the questionnaire of 
patients who participated in the study at least until the 
end of the fourth week. At the end of the eighth week, 
the scores of the VAS and RMDQ of subjects in week 
0, 4, and 8 were compared with each of her and also 
compared with those of the other group (9, 10) . 
 
Statistical Analyses 
SPSS software (IBM SPSS for Windows, 
Version 20.0, IBM Corp., Armonk, NY, USA) was used 
for Statistical analyses. Repeated measure ،Friedman's 
non-parametric test and paired t-test were used to 
compare the results. P-values of less than 0.05 were 
considered statistically significant. 
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Results 
Determination of total phenolic and total flavonoid content  
The total phenolic content of each tablet was 945.4 ± 6.74 mg GAE/g respectively. The total flavonoid 
content of each tablet was 382.15 ± 4. 33 mg of CE/g of dry extract respectively by reference to the related standard 
curves. 
Clinical trial 
A total of 50 patients from both groups were present until the end of the study and were followed up. Of 
these, 54% were female and 46% were male, with an average age of 43 years (Standard deviation of 8.9). The mean 
BMI was 46.26 with a standard deviation of 3.88.  
Comparison of pain intensity in three times with Friedman test showed that the pain intensity of the samples 
in the control group was statistically significant (p-value≤0.001).  
 
Table 1: Comparison of pain intensity in the intervention and control groups in first, second and third visits. 
 
To compare the Roland-Morris test scales in three times, a repeated measurement was used in both 
intervention and control groups. 
Table 2 shows that the test score before intervention in the two groups does not have a significant difference 
(p-value=0.822) and the two groups are identical. The difference between the scores of the Roland-Morris test after 4 
weeks (p-value=0.049) of treatment and 8 weeks (p-value=0.000) of treatment in the intervention and control groups 
was significant. 
 
Table 2: Test score before intervention in the two groups 
 
The Repeated measures test also showed that in the intervention group, the Roland-Morris scores were 
significantly different in each of the three incremental measurements, ie, the status of the samples in the second turn 
was better than the first one, and in the third turn, recovery was still greater than before. Also, the difference between 
the third-order Roland-Morris score and the second turn is significant (p-value ≤0.001). 
 
Table 3: The Repeated measures test between two groups  
 
Group Time N Mean Std. Deviation p-value 
Exposure 
Before 26 2.35 0.797 
p-value 
≤0.001 
After 4 weeks 26 1.69 0.788 
After 8 weeks 26 1.04 0.528 
Control 
Before 24 2.08 0.584 
0.607 After 4 weeks 24 2.12 0.448 
After 8 weeks 24 2.21 0.588 
Time Group Mean Std. Deviation N p-value 
Before exposure 11.62 4.691 26 0.822 
control 11.33 4.050 24 
After 4 weeks exposure 8.31 4.889 26 0.049 
control 10.71 3.263 24 
After 8 weeks exposure 4.35 3.273 26 0.000 
control 10.46 3.489 24 
Exposer Time Mean Std. Error p-value 
95% Confidence Interval 
Lower Bound Upper Bound 
Exposure 
Before 11.615 0.862   9.882 13.349 
After 4 weeks 8.308 0.822 0.000 6.656 9.960 
After 8 weeks 4.346 0.663   3.014 5.678 
Control 
Before 11.333 0.897 0.131 9.529 13.137 
After 4 weeks 10.708 0.855   8.989 12.428 
After 8 weeks 10.458 0.690   9.072 11.845 
Published online in http://ijam. co. in 
30 
International Journal of Ayurvedic Medicine, 2019, 10(1), 27-33 
ISSN: 0976-5921 
The Roland-Morris Disability Questionnaires 
showed that the disability level in the intervention group 
in the fourth and eighth weeks was significantly lower 
than the control group (P<0.002) (Figure 1). 
The results indicated the significant reduction in 
the pain severity in the intervention group. Therefore, it 
can be concluded that the Rhazes tablet reduced the pain 
in the intervention group compared with the placebo in 
the control group (P<0.039). 
 
Figure 1: Roland-Morris Disability Questionnaires 
in the intervention and control groups First, second 
and third visits  
 
 
Figure 2: Study flowchart 
 
 
Discussion  
LBP is a common disorder and a considerable 
economic burden in industrialized countries. A large 
number of patients with LBP use complementary and 
alternative medicine for relief of their pain. Finding 
effective and suitable therapy is vital for these patients, 
clinicians and policy makers. numerous herbal 
medications have been applied in treatment of LBP. 
 Comparing the results of the pain severity 
variable before and after the study showed that Rhazes 
tablet significantly decreased the pain severity based on 
the VAS scale in the patients with LBP. The Roland-
Morris Disability Questionnaires also demonstrated that 
the disability level in the intervention group. In the 
fourth and eighth weeks was significantly lower than the 
control group. Also, comparing the results of pain 
intensity based on VAS values in patients with LBP at 
the end of the fourth and eighth weeks of the study 
showed that the severity of pain decreased significantly 
at the end of the fourth week compared to the eighth 
week. 
According to our search in available databases 
(PUBMED, EMBASE) there is no definite research on 
Rhazes Tablet formula. However, there are many 
studies about positive effects of herbal drugs on LBP. 
For example, Frerick et al. investigated the effect of red 
pepper on chronic LBP in the clinical trial, and the 
results showed that the severity of pain in red pepper-
treated patients was significantly less than that of the 
control group (11). Chrubasik et al also investigated the 
effect of willow bark on the LBP and the result showed 
a significant reduction in the severity of pain in the 
group consuming the product than that of the control 
group (12). The results of this of revealed that the 
highest reduction in the pain severity was observed in 
week 4 as well as willow bark in Chrubasik et al study. 
The pain reduction rate was reduced by 53.87% at the 
end of the study compared to than at the beginning of 
study. 
Primary mechanisms of pain reduction in Rhazes 
Tablet are related to the herbal ingredients. So, a brief 
look to the agents lead to better understanding of the 
effects: 
Colchicum autumnal is a member of the 
Colchicaceae plant family and over 100 species of this 
plant exist around the world. The main active ingredient 
of this herb is colchicine, a kind of alkaloid, was found 
to be effective in control of the pain and inflammation 
(13, 14). Colchicine is a natural product originally 
extracted from plants of the genus Colchicum autumnal 
(autumn crocus) and has been used to treat gouty 
arthritis for centuries (15). Studies have demonstrated 
that low-dose colchicine is effective for the 
management of acute gout flares as well as for long-
term prophylactic maintenance (16). Oral intake of 
colchicine has inhibited the expansion of edema in rats 
and has displayed anti-inflammatory characteristics(17). 
The precise mechanism of action of colchicine in pain 
relief remains uncertain (18, 19). It has been recognized 
that colchicine binds to both α- and β-tubulin, and make 
a complex which inhibits microtubules formation. Thus, 
routes of inflammatory mediators creation that need 
microtubules, such as recruitment of cytosolic 
component (mitochondria) or proteins (kinases), are 
disposed to colchicine treatment (20). Also, Colchicine 
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reduces the process of inflammation and, as a 
consequence, the remission and treatment of gout 
attacks. Colchicine also works in the treatment of other 
chronic inflammatory diseases (21, 22). 
 Aloe vera as a medicinal herb is containing a 
number of pharmacologically-active elements useful for 
the treatment of different diseases such as radiation 
burns, ulcers, arthritis, and diabetes. It contains vitamins 
(vitamin A, C, E, and B12, that act as antioxidants), 8 
enzymes (aliases, alkaline phosphatase, amylase, 
bradykinase, carboxypeptidase, catalase, cellulase, 
lipase, and peroxidase (23, 24). Bradykinase reduces 
excessive inflammation, and others cause sugars and 
fats breakdown), minerals (calcium, chromium, copper, 
selenium, magnesium, manganese, potassium, sodium 
and zinc), 12 anthraquinones (which are laxatives), and 
hormones (Auxins and gibberellins that act in wound 
healing and have anti-inflammatory effects) (25, 26). 
Aloe vera is potent anti-inflammatory agent (12, 
27). It decreases prostaglandin E2 production by 
cyclooxygenase pathway inhibition. Previous 
investigation has indicated that the C-glucosyl 
chromone as a novel anti-inflammatory compound 
exists in Aloe vera (28, 29).  Aloe vera gel has been 
used dermally to decrease joint pains by tradition. 
Phytochemical analysis of Aloe vera revealed the 
existence of flavonoids, alkaloids, resins, tannins, 
steroids and other chemical substances (30, 31). 
Studies have shown that carboxypeptidase (one 
of the Aloe vera ingredients) could deactivate 
bradykinin, which is a powerful factor causing pain 
during the acute inflammation. Furthermore Salicylic 
acid, which is found in Aloe vera, works as a painkiller, 
analgesic, and anti-inflammatory factor by inhibiting the 
production of prostaglandins (32, 33). 
Terminalia chebula has strong antioxidant effects 
and protects cellular organelles from the radiation-
induced damage (34). Terminalia chebula is effective 
for healing wounds and treats wounds quickly, as 
indicated by the increased rates of contraction and 
decreased periods of epithelialization. Biochemical 
studies show a significant increase in total protein, 
DNA, and collagen content in the granulation tissues of 
treated wounds. In addition, this plant has antimicrobial 
and antioxidant properties. These results confirm the 
beneficial effects of Terminalia chebula on the 
acceleration of healing (35, 36). 
Commiphora wightii resin produced from 
Commiphora wightii is reported for many therapeutic 
effects in Ayurvedic medicine. The essential oils 
derived from peptides are effective in the treatment of 
rheumatism, arthritis, hyperlipidemia, and obesity. It 
also has anti-inflammatory and antimicrobial and anti-
fungal effects. Commiphora wightii essential oil 
includes polymyrecene, Z-gugglusterone and myrecene, 
dimyrecene, E-gugglusterone, gugglusterone-I, 
gugglusterone-II, and gugglusterone-III. These isolates 
have been useful in curing rheumatism, arthritis, 
hyperlipidemia, obesity, inflammation, atherosclerosis, 
wrinkles, acne and other diseases (37, 38). 
Astragalus gossypinus is a large genus of herb 
and shurb, belonging to family Fabaceae. The analgesic 
effects of Astragalus gossypinus gum, on stomach pains 
and headache have been reported in Persian medicine 
(39, 40). 
Cuminum cyminum has been used in traditional 
medicine to treat some disorders like hyper-lipidemia, 
cancer, and diabetes. The presence of monoterpene 
compounds, Linalool, γ-terpinene α-pinene and β-
pinene contribute largely to anti-inflammatory activity 
of the Cuminum cyminum (41) . There are also several 
reports on the anti-oxidant properties of this plant.  
Zingiber officinale contains numerous known 
ingredients such as gingerols, beta-carotene, capsaicin, 
caffeic acid, and curcumin. Furthermore, salicylate is 
one of the other components which have been found in 
ginger (42). Ginger inhibits both cyclooxygenase 
(COX) and lipooxygenase together, to prevent 
leukotriene production (43). One study in 2010 has been 
demonstrated that daily intake of ginger led to the 
moderate-to-large decrease in muscle pain following 
exercise-induced muscle injury. Their results have 
shown ginger's efficacy as a pain reliever (11, 44). 
Pipper nigrum is known for its pungent 
constituent piperine (effective ingredient in black 
pepper). Based on the modern cell, animal, and human 
studies, piperine has been found to have immune-
modulatory, anti-oxidant, morphine like and anti-
inflammatory properties (45, 46). 
 
Conclusion 
In the present study, the effectiveness of Rhazes 
formula in pain reduction (by using VAS score) and 
improving quality of life (by Roland-Morris 
questionnaire) were surveyed in patients with chronic 
LBP in a double-blind trial. The results of this trial 
indicated that Rhazes tablet reduces the pain and 
improve quality of life of patients with LBP. 
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